市場調查報告書
商品編碼
1541656
2024-2032 年按產品類型(醫用樹脂和纖維、醫用彈性體、可生物分解塑膠)、應用(醫療設備和裝置、醫用包裝等)和地區分類的醫用聚合物市場報告Medical Polymers Market Report by Product Type (Medical Resins and Fibers, Medical Elastomers, Biodegradable Plastics), Application (Medical Equipment and Devices, Medical Packaging, and Others), and Region 2024-2032 |
IMARC Group年全球醫用聚合物市場規模達219億美元。
醫用聚合物包括用於製造再生醫學和組織工程藥物的散裝材料、塗層和藥物奈米載體。它們具有多功能性、強度、靈活性、生物分解性、生物相容性、滅菌穩定性以及疲勞、耐熱和電阻。一些製造商目前正在證明不同類型的醫用聚合物,具有調整的分子量、交聯和結晶度、共聚物和共混物,以及額外的生物活性表面功能化。此外,對新型和創新醫療設備的需求不斷成長,全球對醫用聚合物的需求也不斷增加,以支持設備的開發和永續性。
診斷和治療冠狀病毒病 (COVID-19) 患者對拭子、醫療設備、一次性口罩和個人防護裝備 (PPE) 的需求不斷成長,這是推動醫用聚合物需求的關鍵因素之一。除此之外,傳染病、慢性病、心血管病和其他慢性病的日益普及正在推動先進醫療設備的採用,這反過來又促進了市場的成長。此外,許多國家的政府正在資助醫療研究與發展 (R&D) 項目,以改善醫療保健基礎設施。除此之外,由於老年人口不斷增加和事故數量不斷增加,對器官移植的需求也不斷增加,也推動了市場的發展。此外,醫療旅遊的興起和家庭醫療保健服務的日益普及正在推動市場成長。領先的市場參與者也專注於引入新型複雜的生物聚合物,預計這將增強醫用聚合物在骨科穩定材料和血管支架中的應用。
The global medical polymers market size reached US$ 21.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 39.1 Billion by 2032, exhibiting a growth rate (CAGR) of 6.5% during 2024-2032.
Medical polymers comprise bulk materials, coatings, and pharmaceutical nano-carriers used for making drugs in regenerative medicine and tissue engineering. They offer versatility, strength, flexibility, biodegradability, biocompatibility, sterilization stability, and fatigue, heat, and electrical resistance. Several manufacturers are currently proving different types of medical polymers with adjusted molecular weight, crosslinking and crystallization degrees, copolymers and blends, and additional bioactive surface functionalization. Moreover, the growing demand for new and innovative medical devices is escalating the need for medical polymers worldwide to support device development and sustainability.
The rising need for swabs, medical devices, disposable masks, and personal protective equipment (PPE) to diagnose and treat individuals with coronavirus disease (COVID-19) represents one of the key factors impelling the demand for medical polymers. Apart from this, the increasing prevalence of infectious, chronic, cardiovascular, and other chronic diseases is propelling the adoption of advanced medical devices, which, in turn, is contributing to the market growth. Additionally, governments of numerous countries are financing medical research and development (R&D) projects to improve healthcare infrastructure. Besides this, the increasing need for organ transplantation due to the growing geriatric population and escalating number of accidents is driving the market. Furthermore, the emerging trend of medical tourism and the increasing popularity of home healthcare services are promoting the market growth. The leading market players are also focusing on introducing new and sophisticated biopolymers, which is projected to enhance the application of medical polymers in orthopedic stabilizing materials and vascular stents.
IMARC Group provides an analysis of the key trends in each sub-segment of the global medical polymers market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product type and application.
Medical Resins and Fibers
Polyvinyl Chloride
Polypropylene
Polyethylene
Polystyrene
Others
Medical Elastomers
Styrene Block Copolymer
Rubber Latex
Others
Biodegradable Plastics
Medical Equipment and Devices
Medical Packaging
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being BASF SE, Celanese Corporation, Covestro AG, DuPont, Eastman Chemical Company, Evonik Industries AG, Exxon Mobil Corporation, Huizhou Foryou Medical Device Co. Ltd., Kraton Corporation and Solvay S.A.